Download Citation
Article Source:
Correction: High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation
The PLOS ONE Staff
(2014)
Correction: High-Throughput Screening Identifies Idarubicin as a Preferential Inhibitor of Smooth Muscle versus Endothelial Cell Proliferation.
PLOS ONE 9(10): e110098.
https://doi.org/10.1371/journal.pone.0110098